[HTML][HTML] Coumarin derivatives as acetyl-and butyrylcholinestrase inhibitors: An in vitro, molecular docking, and molecular dynamics simulations study

MN Abu-Aisheh, A Al-Aboudi, MS Mustafa… - Heliyon, 2019 - cell.com
Alzheimer's disease is an irreversible and progressive brain disease that can cause
problems with memory and thinking skills. It is characterized by loss of cognitive ability and …

Discovery of promising cholinesterase inhibitors for Alzheimer's disease treatment through DFT, docking, and molecular dynamics studies of eugenol derivatives

H Nour, A Abdou, S Belaidi, JE Jamal… - Journal of the …, 2022 - Wiley Online Library
Cholinesterase enzymes are promising drug targets for the symptomatic treatment of
Alzheimer's disease. Indeed, the activity inhibition of these acetylcholine‐degrading …

Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives

A Saeed, S Zaib, S Ashraf, J Iftikhar, M Muddassar… - Bioorganic …, 2015 - Elsevier
Alzheimer's disease is among the most widespread neurodegenerative disorder.
Cholinesterases (ChEs) play an indispensable role in the control of cholinergic transmission …

Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and …

AH Hasan, S Murugesan, SI Amran, S Chander… - Bioorganic …, 2022 - Elsevier
A series of around eight novel chalcone based coumarin derivatives (23a-h) was designed,
subjected to in-silico ADMET prediction, synthesized, characterized by IR, NMR, Mass …

Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies

H Cavdar, M Senturk, M Guney, S Durdagi… - Journal of enzyme …, 2019 - Taylor & Francis
Abstract Acetylcholinesterase (AChE) and Butyrylcholinesterase (BuChE) inhibitors are
interesting compounds for different therapeutic applications, among which Alzheimer's …

Synthesis, biological evaluation and molecular modeling studies of modulated benzyloxychalcones as potential acetylcholinesterase inhibitors

A Abdalla Ali, SA Mhamad, AH Hasan… - Journal of …, 2024 - Taylor & Francis
Acetylcholinesterase inhibitors (AChEIs) have become a significant target in the search for
an efficient treatment of Alzheimer's disease. Chalcone-based compounds display a strong …

Design, Synthesis, Biological Evaluation, and Molecular Modeling of Coumarin–P iperazine Derivatives as Acetylcholinesterase Inhibitors

RP Modh, SP Kumar, YT Jasrai… - Archiv der …, 2013 - Wiley Online Library
Acetylcholinesterase (AChE) is an important drug target for the treatment of Alzheimer's
disease. A novel series of coumarin–piperazine derivatives were synthesized and their …

Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors

F Sonmez, B Zengin Kurt, I Gazioglu… - Journal of enzyme …, 2017 - Taylor & Francis
New coumaryl-thiazole derivatives with the acetamide moiety as a linker between the alkyl
chains and/or the heterocycle nucleus were synthesized and in vitro tested as …

Novel coumarin derivatives as potent acetylcholinesterase inhibitors: insight into efficacy, mode and site of inhibition

P Baruah, G Basumatary, SO Yesylevskyy… - Journal of …, 2019 - Taylor & Francis
The inhibitory efficacy of two substituted coumarin derivatives on the activity of
neurodegenerative enzyme acetylcholinesterase (AChE) was assessed in aqueous buffer …

Characterization of the interactions between coumarin-derivatives and acetylcholinesterase: Examination by NMR and docking simulations

NU Tanoli, SAK Tanoli, AG Ferreira… - Journal of Molecular …, 2018 - Springer
Alzheimer's disease (AD) is one of the most common forms of dementia and a significant
threat to the elderly populations, especially in the Western world. The rapid hydrolysis of the …